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Abstract
Background: The quality of diabetes care provided to older adults has usually been judged to be
poor, but few data provide direct comparison to other age groups. In this study, we hypothesized
that adults age 65 and over receive lower quality diabetes care than adults age 45–64 years old.
Methods: We conducted a cohort study of members of a health plan cared for by multiple medical
groups in Minnesota. Study subjects were a random sample of 1109 adults age 45 and over with an
established diagnosis of diabetes using a diabetes identification method with estimated sensitivity
0.91 and positive predictive value 0.94. Survey data (response rate 86.2%) and administrative
databases were used to assess diabetes severity, glycemic control, quality of life, microvascular and
macrovascular risks and complications, preventive care, utilization, and perceptions of diabetes.
Results: Compared to those aged 45–64 years (N = 627), those 65 and older (N = 482) had better
glycemic control, better health-related behaviors, and perceived less adverse impacts of diabetes
on their quality of life despite longer duration of diabetes and a prevalence of cardiovascular disease
twice that of younger patients. Older patients did not ascribe heart disease to their diabetes.
Younger adults often had explanatory models of diabetes that interfere with effective and
aggressive care, and accessed care less frequently. Overall, only 37% of patients were
simultaneously up-to-date on eye exams, foot exams, and glycated hemoglobin (A1c) tests within
one year.
Conclusion: These data demonstrate the need for further improvement in diabetes care for all
patients, and suggest that customisation of care based on age and explanatory models of diabetes
may be an improvement strategy that merits further evaluation.
Background
At present, about 4–5% of U.S. adults age 18 and over
have diagnosed type 2 diabetes [1] In various popula-
tions, the median age of adults with diabetes typically
ranges from 59 to 64 years [2] In the last decade, the over-
all incidence of diabetes in America has risen due to
increasing obesity, inactivity, and population aging –
despite new diagnostic criteria for diabetes based on fast-
ing glucose that may be less likely to classify elderly
patients as having diabetes [3–6]
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The care of older patients with diabetes presents special
clinical challenges and opportunities [7] Clinicians may
tailor diabetes care based on a patient's age, functional
status, attitudes towards diabetes, or other factors [8,9]
Some physicians may treat diabetes less aggressively in
elderly patients [10,11] due to anticipated short life
expectancy, fear of hypoglycemia, or other factors [12]
However, there are many adverse short-term conse-
quences of inadequately controlled diabetes, including
excess hospitalizations, increased costs [13] and decreased
quality of life [14–16] While the majority of previous
studies suggest general under treatment of diabetes in the
elderly, at least one prior report suggests this may not be
the case [17]
We hypothesized that quality of diabetes care varies by
age, and that older patients receive lower quality diabetes
care than younger patients. To test this hypothesis, we
analyzed care received by diabetes patients 65 years and
over, and compared it to care received by those 45–64
years old, in the following clinical domains: (1) glycemic
control, (2) cardiovascular risk factor profiles including
cholesterol, hypertension, smoking cessation, physical
activity, and aspirin use, (3) screening for microvascular
complications, (4) general preventive care, and (5)
patient education and utilization of care [5,18–20] In
addition, we attempt to understand how patient assess-
ments of the seriousness of diabetes may vary with age.
We and others have previously hypothesized that patient
views of the seriousness of diabetes may be a key factor in
understanding variation in diabetes care [9,21]
Methods
This study was conducted at HealthPartners, a large mixed
model managed care organization in the Twin Cities with
about 650,000 members in owned clinics and contracted
clinics. Adults age 19 years and older who were continu-
ously enrolled in calendar year 1994 were defined as hav-
ing diabetes if they had either (a) two or more clinic visits
with a primary or secondary diagnosis of diabetes mellitus
(defined as any ICD-9 250 code) during 1994, or (b) one
or more filled prescriptions for a diabetes-specific drug
including insulin, sulfonylureas, or biguanides in 1994.
This strategy for identifying diabetes in this health plan
has an estimated sensitivity of 0.91, specificity of 0.99,
and positive predictive value of 0.94 as previously
reported [22]
A random sample of 1828 health plan members with dia-
betes was drawn from all adults with diabetes attending
either owned or contracted clinics. These members were
surveyed in July 1995 by mail with telephone follow-up,
with an 85.6% corrected response rate (N = 1565). After
exclusions for age under 45 years and for incomplete data
on all variables of interest, 1109 study subjects, including
610 in owned clinics and 499 in contracted clinics were
included in the analysis and are the basis of this report.
The 16-page, 61-item diabetes survey included questions
from the Centers for Disease Control's (CDC) Behavioral
Risk Factor Surveillance System (BRFSS) core items and
diabetes module. Data collected included demographics,
disease characteristics, comorbidity, duration of diabetes,
diabetes treatment, preventive care, diabetes monitoring,
self-care practices, and other topics.
Additional administrative data including number of pri-
mary care visits, visits with specialists, dilated retinal
exams, and glycated hemoglobin (A1c) results from the
12 months prior to the survey were linked to survey
responses before purging all personal identifiers. All A1c
assays were performed at the same centralized, accredited
clinical chemistry laboratory using a high pressure liquid
chromatographic assay with a normal range of 4.5% to
6.1% and a coefficient of variation of 0.58% at a A1c level
of 8.8% [23] Of 610 study subjects enrolled in owned
clinics, 517 (84.8%) had at least one A1c test done in the
12-month period prior to the survey. However, compara-
ble A1c data were not available for contracted clinics,
which used various laboratories and laboratory reporting
systems.
Intensity of diabetes care was measured across several
clinical domains. Glycemic control was assessed using
laboratory data to calculate A1c test rates and A1c values.
Macrovascular risk factor control was measured by patient
report of aspirin use, smoking status, physical activity,
body mass index, and rates of patient-reported hyperten-
sion, lipid disorders, and heart disease. Screening for
microvascular complications was measured by self-
reported eye exam rates and foot exam rates. General pre-
ventive care was measured by self-report of preventive care
exams, blood pressure checks, and immunization rates.
Utilization of care was measured through survey ques-
tions and from administrative data.
Initial analysis of data used the Chi-square statistics or t-
tests to evaluate the relationship between patient age
group and measures of the relevant clinical domains. Mul-
tivariate modelling of the data was then done using logis-
tic regression and least-squares linear models [24] to
adjust for covariates including gender, race, years of edu-
cation, duration of diabetes, and whether the patient
attended an owned or contracted clinic. The main a priori
hypothesis of difference in quality of diabetes care is
based on measured differences in A1c values and is tested
at a two-tailed alpha of 0.05 after multivariate adjustment
for relevant patient characteristics. Secondary measures of
quality of care were numerous, and an alpha of 0.01 is
suggested to appropriately assess significance [25] Previ-
ous analysis of clustering of A1c values within clinics ofBMC Family Practice 2003, 4 http://www.biomedcentral.com/1471-2296/4/16
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the medical group demonstrated that this was not a signif-
icant factor, [26,27] and therefore results from ordinary
least squares and logistic models are presented.
Results
Table 1 shows characteristics of study subjects age 45 to 64
years compared to those age 65 or over. As expected, the
distribution of gender, race, educational, marital status,
and duration of diabetes varied with age. Therefore, when
analyzing the effect of age on dependent variables, multi-
variate models were used to adjust for the effect of poten-
tially confounding variables such as gender, educational
level, owned versus contracted of clinic, and duration of
diabetes. The 8.9% of those age 45 to 64 years who had
diabetes diagnosis before at age 30 years and were on
insulin treatment only had no significant differences.
Table 2 shows data on glycemic control by age group, after
adjustment in multivariate models for gender, educa-
tional level, race, marital status, and duration of diabetes.
There were 610 study subjects enrolled in health plan-
owned clinics, and 517 of these had two or more A1c tests
available for analysis. The proportion of patients with A1c
tests did not differ significantly by age. Mean A1c was
8.4% in younger patients and 8.0% in older patients. The
percent of patients with A1c > 10% was 16.5% in younger
patients and 6.4% in older patients (p = 0.008). The per-
cent of patients with A1c < 8% was 43.9% in younger
patients, and 57.6% in older patients (p = 0.038). Thus,
after adjusting for potential confounders, older subjects
with diabetes had significantly better glycemic control
than younger adults with diabetes had.
Table 3 shows data on cardiovascular risk factors by age
group. Older patients had nearly twice as much self-
reported heart disease and significantly higher self-
reported hypertension than younger patients. However,
older patients did not generally attribute their cardiovas-
cular comorbidities to having diabetes. After adjustment
for gender, educational level, marital status, race, and
duration of diabetes, older adults had significantly lower
levels of obesity and overweight, more physical activity,
less current and former smoking, and higher rates of aspi-
rin use. As expected, older adults also reported higher
rates of cardiovascular comorbidities, hypertension, and
high cholesterol.
Table 4 shows use of preventive care services by age. The
rate of dilated eye exams within one year was 58.9% in
younger patients and 67.2% in older patients by self-
report (p = 0.04), and was 56.4% in younger patients and
77.7% in older patients in health plan owned clinics
based on a standard set of procedure codes for diabetes
eye exams (p = 0.006) [28] Two or more physician foot
exams were reported within one year by 60.5% of younger
patients and 64.5% of older patients (p = 0.06). The mean
number of foot exams within one year was 1.3 in younger
Table 1: Unadjusted demographic, social, and health characteristics of 1109 adults with diabetes. P-values address differences between 
age groups.
Variable 45–64
N = 627
65+
N = 482
p-value
Analysis Demographics (% Of respondents):
Mean Age (years) 55 73.2 N/A*
Gender (% male) 53.6 49.0 0.126
Education (% >= high school) 67 47.1 <0.001
Race: White (%) 87.9 95 <0.001
Ethnicity: Latino (%) 1.5 1.8 0.72
Marital Status (% married) 77.5 66.8 <0.001
Employed for Wages (%) 63.5 5.2 <0.001
Clinic-type (% in Owned Clinics) 46.9 65.6 <0.001
Diabetes Demographics
Mean Age at Diagnosis (Years) 45.7 61.5 <0.001
Mean Duration of Diabetes (Years) 9.3 11.7 <0.001
Age at Diagnosis < = 30 Years (%) 9.7 1.9 <0.001
Age at Diagnosis < = 30 Years and using Insulin (%) 8.9 0.6 <0.001
Diabetes Medications/Treatment
Any Insulin Use (% Yes) 42.4 35.7 0.023
Insulin Use Only (%) 37.6 31.1 0.024
Any Oral Medications (%) 44.7 45.6 0.744
Oral Medications Only (%) 39.9 41.1 0.685
* Not ApplicableBMC Family Practice 2003, 4 http://www.biomedcentral.com/1471-2296/4/16
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patients and 1.8 in older patients (p < 0.001). Immuniza-
tion rates were higher in older patients, but use of other
preventive care and dental care were not significantly
related to age.
The proportion of patients who believed their doctor was
good at working with them to modify treatment plans was
84% and did not differ by age. Younger patients more
often reported that their doctor asked them to take some
responsibility for their diabetes treatment (59.4% vs.
44.1%). Younger and older patients had similar confi-
dence in their ability to adjust medications (63%), and
perform home glucose monitoring (82%).
Attitudes towards diabetes varied with age. Younger
patients (8–16% on various questions) reported that dia-
betes made life more difficult, and reported feeling more
unhappy and depressed and more diabetes-related dissat-
isfaction with their lives than older patients (6–11% on
various questions). Older patients reported diabetes inter-
fered with travel and caused financial difficulties, while
younger patients reported that diabetes interfered with the
types and amounts of food they ate. Overall social support
was greater (p < 0.001) for those 65 and over, while more
younger adults (88.5%) than older adults (77.6%) had
people depending on them (p = 0.001). Finally, self-
reported health status was significantly better (p = 0.01)
for those 45–64 years old than those 65 years and over.
Table 5 shows utilization of care data. Both younger and
older patients self-reported a mean of 2.8 visits for diabe-
tes care each year. However, physicians coded a diabetes
diagnosis at 5.6 visits per year in younger patients and 6.7
visits per year in older patients. Diagnostic codes indicate
that 83.3% of younger patients and 92.0% of older
patients had two or more diabetes visits within one year.
About 98% of all patients identified a regular clinic, and
88% identified a regular provider of diabetes care, with no
Table 2: Measures of glycemic control for study subjects with diabetes (N = 610) enrolled in clinics with automated laboratory data, by 
age group, after adjustment for gender, educational level, marital status, race, and duration of diabetes. All data in this table based on 
automated laboratory databases.
Variable N 45–64 Years 65+ Years p-value
Percent of subjects with at least one A1c test in the last year. 610 81.3 88.0 0.055
Percent of subjects with two or more A1c measures in the last year. 610 53.4 60.8 0.242
Average number of A1c tests in the last year in those with any A1c test. 517 2.1 2.3 0.112
Percent of subjects with A1c <8% 517 43.9 57.6 0.038
Percent of subjects with A1c ≥ 10% 517 16.3 6.5 0.008
Table 3: Cardiovascular comorbidity and risk measures of 1109 adults with diabetes, by age group, after adjustment for gender, 
educational level, marital status, race, and duration of diabetes.
Variable 45–64 Years
N = 627
65+ Years
N= 482
p-value
Mean Body Mass Index (kg/m2) 31.1 28.7 <0.001
Percent Overweight '98 (BMI >25) 85.2 74.5 <0.001
Percent Obese '98 (BMI >30) 53.1 32.8 <0.001
Percent Current Smoker 17.9 6.0 <0.001
Percent Ever Smoker 66.8 56.2 <0.001
Percent Taking Aspirin at least 3× 
per week
29.0 43.6 <0.001
Days in last week with physical 
activity for 30 minutes or more
4.6 5.1 0.002
Percent told by a health 
professional they had heart trouble
20.4 41.5 <0.001
Percent told by a health 
professional they had high blood 
pressure
52.6 64.5 0.002
Percent told by a health 
professional they had high 
cholesterol
42.7 37.3 0.08BMC Family Practice 2003, 4 http://www.biomedcentral.com/1471-2296/4/16
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differences by age. Outpatient primary care visits, outpa-
tient specialty care visits, and number of hospitalisations
were all significantly higher in older versus younger
patients, after adjustment for gender, educational level,
marital status, race, and duration of diabetes.
Discussion
Quality of diabetes care depends upon many factors,
including characteristics of health insurance, medical
groups, clinics, providers, and patients(10, 29, 30) In this
report, we focus on an especially interesting piece of the
puzzle – how diabetes care and outcomes relate to patient
age and patient attitudes towards diabetes. Is such a nar-
row focus on patient-related factors justified? Previous
studies and our data suggest that patient factors such as
age and attitudes towards diabetes may contribute signif-
icantly to undesirable variation in diabetes care [26] If this
is so, customization of diabetes care based on patient age,
attitudes towards diabetes, comorbidity, risk of complica-
tions, or other factors may be an improvement strategy
that can lead to better diabetes care and outcomes.
There were distinct differences in patterns of care and
quality of care by age. Older patients had longer duration
of diabetes, higher cardiovascular comorbidity, poorer
perceived health status, and higher inpatient and outpa-
tient utilization rates. Older patients also had better glyc-
emic control even though they were less often treated with
insulin, more often treated with no diabetes medications,
and did less home glucose monitoring. These differences
in health and in diabetes care by age across multiple clin-
ical domains persisted after control in multivariate mod-
els for educational level, gender, functional health status,
duration of diabetes, and type of diabetes treatment.
Thus, among older patients, the burden of diabetes
appeared to be increasingly mediated through the cardio-
vascular complications of diabetes. Despite their longer
duration of diabetes and much higher rates of cardiovas-
cular disease, older patients had less negative views of dia-
betes and reported less adverse impact of diabetes on their
lives than did younger patients. The data suggest that
older patients do not attribute cardiovascular-comorbidi-
ties to their diabetes. Many diabetes patients, most espe-
cially older diabetes patients, appear to seriously
underestimate the adverse effect diabetes may have on
their health.
Although the overall level of diabetes care in this setting
was better than reported in many other settings, [31–34]
few patients received all recommended elements of care.
For example, while eye exam rates were 66%, A1c test rates
were over 85%, and foot exam rates were 62%, only 36%
of all patients received all these elements of care within
the past year. Older patients had higher prevalence of car-
diovascular risk factors, but relatively better risk factor
control, with lower rates of smoking, higher rates of aspi-
rin use, lower rates of obesity, and more physical activity.
Because this is a cross-sectional study, some of these age-
related differences could be partially explained by selec-
tive mortality.
There is ample evidence that glycemic control could be
further improved even in older patients [35,36] However,
attention to reversible cardiovascular risks, including
more use of aspirin, [30,37] better control of blood pres-
sure [38–41] and better lipid control [42,43] may be the
best strategy to improve care for patients who are already
in reasonably good glycemic control [44,45] Improve-
ment strategies deployed through primary care clinics
may be effective, because older patients had frequent pri-
mary care visits. Successful strategies to improve chronic
disease care in primary care practices using guidelines, reg-
istries, and more organized office care have been reported
recently [46–53]
Table 4: Preventive care and other measures of 1109 adults with diabetes, by age group, after adjustment for gender, educational level, 
marital status, race, and duration of diabetes.
Variable 45–64
Years N = 627
65+ Years
N = 482
p-value
Percent with self-report of good/very good/excellent general health 74.3 65.6 0.01
Percent with a visit for a routine check-up within one year 83.9 86.1 0.19
Percent with blood pressure taken by health professional within one year 95.2 94.2 0.85
Percent with cholesterol check within one year 78.2 73.2 0.15
Percent with dental check-up within one year 68.4 65.4 0.08
Percent with an influenza immunisation within 1 year 56.1 82 <0.001
Percent ever having a pneumonia immunisation 31.3 64.7 <0.001
Percent with a dilated eye exam within one year 59.2 67.0 0.04
Percent with one or more foot checks within one year 60.8 64.9 0.06
Percent with two or more foot checks within one year 35.1 44.0 0.006BMC Family Practice 2003, 4 http://www.biomedcentral.com/1471-2296/4/16
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Relative to those age 65 years and over, those age 45 to 64
years did relatively poorly with their diabetes care.
Younger patients had worse glycemic control, higher rates
of obesity, smoked more, and were less physically active –
factors associated with high costs [54] and high mortality
[8,55–57] in diabetes patients. Intriguing clues in the data
suggest that many patients in the 45–64 year group may
be either too busy to take care of their diabetes, or have
"explanatory models" of diabetes that may reduce their
motivation to care for the disease. Previous qualitative
and quantitative studies have linked specific explanatory
models to poor diabetes care and outcomes, and those
with shorter duration of diabetes may be in more "denial"
than those with longer duration disease [21,58]
In a time when variation in care is often viewed nega-
tively, the data reported here suggest the need to custom-
ize diabetes care to accommodate patient factors, such as
age, comorbidity, functional health status, and attitudes
towards diabetes [59–62] "Mass customization" theory
provides insight on how to achieve better self-care behav-
iors and clinical outcomes [63–66] Such care models may
be especially suitable in cost-conscious and data-rich prac-
tice settings, such as many health plans. There are several
examples of successful innovation in diabetes care that
provide templates for improvement [49,50,52,53] and it
is interesting to note that practices that have successfully
improved diabetes care have used many of the same basic
strategies: leadership; resource allocation for improve-
ment; clinical guidelines; patient activation; reorganized
care teams; automated information systems to identify,
monitor, and prioritize patients; visit planning, and active
outreach [67,68]
There are several factors that constrain the interpretation
of the data presented here. First, the accuracy of self-
reported data must be considered. We have previously
studied this issue in depth, and sought to use the type of
measure (self-report or database derived) that is most
accurate for a particular variable [28] Thus, comorbidities
such as hypertension and dyslipidemia are based on self-
report, while A1c values, diabetes diagnosis, and utiliza-
tion of care are derived from automated databases. Sec-
ond, the study was limited to insured patients at one
urban managed care organization, and generalizability of
results to other sites, or to populations with different
demographic profiles, may not be justified. Third, in the
population we studied 8.9% of younger subjects and
0.6% of older subjects had both (a) insulin treatment and
(b) diagnosis of diabetes before age 30. We have included
all adults with diabetes in the analysis because it is very
difficult to accurately distinguish type 1 from type 2 dia-
betes in office practice [69]. Finally, investigation of age
effects is a hazardous undertaking, especially in observa-
tional studies with short follow-up periods such as ours.
Age confers increased mortality risks, and associated selec-
tion effects could affect the findings, especially with
respect to prevalence rates of behavioral and biological
risk factors such as smoking that are related to mortality
risk.
Conclusions
We conclude that older patients achieve more recom-
mended goals of diabetes care than younger adult
patients. Despite high rates of heart disease, older patients
fail to ascribe heart disease to their diabetes. Younger
adults often have explanatory models of diabetes that
interfere with effective and aggressive care, and appear to
access care less frequently, despite having comprehensive
pre-paid health insurance. These data demonstrate the
need for further improvement in diabetes care for all
patients, and suggest that customizing care to age and
explanatory models of diabetes may be an improvement
strategy that merits further evaluation.
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